{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:11:54Z","timestamp":1792613514117,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier","isbn-type":[{"value":"9780128201855","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["226546001"],"award-info":[{"award-number":["226546001"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["201601D202058"],"award-info":[{"award-number":["201601D202058"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013794","name":"Department of Education, Shanxi Province","doi-asserted-by":"publisher","award":["201605D111004"],"award-info":[{"award-number":["201605D111004"]}],"id":[{"id":"10.13039\/501100013794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.apha.2019.08.002","type":"book-chapter","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T21:51:44Z","timestamp":1576619504000},"page":"89-112","source":"Crossref","is-referenced-by-count":389,"title":["Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects"],"prefix":"10.1016","member":"78","reference":[{"issue":"11","key":"10.1016\/bs.apha.2019.08.002_bb0010","first-page":"3857","article-title":"SQYZ granules, a traditional Chinese herbal, attenuate cognitive deficits in AD transgenic mice by modulating on multiple pathogenesis processes","volume":"10","author":"An","year":"2018","journal-title":"American Journal of Translational Research"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1142\/S0192415X16500014","article-title":"Astragalus membranaceus: A review of its protection against inflammation and gastrointestinal cancers","volume":"44","author":"Auyeung","year":"2016","journal-title":"The American Journal of Chinese Medicine"},{"key":"10.1016\/bs.apha.2019.08.002_bb0020","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/bs.apha.2019.08.002_bb0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.biopha.2018.04.013","article-title":"The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats","volume":"104","author":"Cai","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.apha.2019.08.002_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jchromb.2012.10.024","article-title":"The experimental study of Astragalus membranaceus on meridian tropsim: The distribution study of astragaloside IV in rat tissues","volume":"911","author":"Chang","year":"2012","journal-title":"Journal of Chromatography B"},{"issue":"6","key":"10.1016\/bs.apha.2019.08.002_bb0035","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1159\/000362974","article-title":"Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats","volume":"33","author":"Chen","year":"2014","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"6","key":"10.1016\/bs.apha.2019.08.002_bb0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bcp.2008.06.020","article-title":"Astragaloside IV improves high glucose-induced podocyte adhesion dysfunction via \u03b13\u03b21 integrin upregulation and integrin-linked kinase inhibition","volume":"76","author":"Chen","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.apha.2019.08.002_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejmech.2016.03.070","article-title":"Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents","volume":"118","author":"Chen","year":"2016","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2019.08.002_bb0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biopha.2018.09.049","article-title":"Astragalosides IV protected the renal tubular epithelial cells from free fatty acids-induced injury by reducing oxidative stress and apoptosis","volume":"108","author":"Chen","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.apha.2019.08.002_bb0055","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.intimp.2014.08.027","article-title":"Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-\u03b1-ERK1\/2-NF-\u03baB pathway","volume":"23","author":"Cheng","year":"2014","journal-title":"International Immunopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2019.08.002_bb0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jbm.a.30249","article-title":"The role of astragaloside in regeneration of the peripheral nerve system","volume":"76","author":"Cheng","year":"2006","journal-title":"Journal of Biomedical Materials Research Part A"},{"issue":"9","key":"10.1016\/bs.apha.2019.08.002_bb0065","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/ptr.5868","article-title":"Reduction of ischemic brain edema by combined use of paeoniflorin and astragaloside IV via down-regulating connexin 43","volume":"31","author":"Chu","year":"2017","journal-title":"Phytotherapy Research"},{"key":"10.1016\/bs.apha.2019.08.002_bb0070","first-page":"1","article-title":"Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: A systematic review","volume":"16","author":"Costa","year":"2018","journal-title":"Current Neuropharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2019.08.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112207","article-title":"Protective effects of astragaloside IV on db\/db mice with diabetic retinopathy","volume":"9","author":"Ding","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2019.08.002_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fphys.2018.00015","article-title":"Astragaloside IV inhibits adipose lipolysis and reduces hepatic glucose production via Akt dependent PDE3B expression in HFD-fed mice","volume":"9","author":"Du","year":"2017","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/bs.apha.2019.08.002_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bbrc.2015.01.002","article-title":"EGFR mediates astragaloside IV-induced Nrf2 activation to protect cortical neurons against in vitro ischemia\/reperfusion damages","volume":"457","author":"Gu","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"10.1016\/bs.apha.2019.08.002_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039824","article-title":"Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo","volume":"7","author":"Gui","year":"2012","journal-title":"PLoS One"},{"issue":"2013","key":"10.1016\/bs.apha.2019.08.002_bb9000","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.cyto.2013.01.008","article-title":"Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-\u03baB-mediated inflammatory genes expression","volume":"61","author":"Gui","year":"2013","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0095","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1038\/s41598-017-07061-7","article-title":"Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPK\u03b1-regulated autophagy induction in streptozotocin-induced diabetic nephropathy","volume":"7","author":"Guo","year":"2017","journal-title":"Scientific Reports"},{"issue":"22","key":"10.1016\/bs.apha.2019.08.002_bb0100","first-page":"4430","article-title":"Protective effect of astragaloside IV on oxidative damages of chang liver cell induced by ethanol and H2O2","volume":"39","author":"Han","year":"2014","journal-title":"China Journal of Chinese Materia Medica"},{"key":"10.1016\/bs.apha.2019.08.002_bb0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature01514","article-title":"Disease proteomics","volume":"422","author":"Hanash","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.apha.2019.08.002_bb0110","first-page":"1078","article-title":"Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin-induced diabetic rat model","volume":"41","author":"He","year":"2018","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.apha.2019.08.002_bb0115","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1159\/000453175","article-title":"Astragaloside IV enhances cisplatin chemosensitivity in non-small cell lung cancer cells through inhibition of B7-H3","volume":"40","author":"He","year":"2016","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"7","key":"10.1016\/bs.apha.2019.08.002_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1142\/S0192415X15500809","article-title":"Effects of the combination of the main active components of Astragalus and Panax notoginseng on inflammation and apoptosis of nerve cell after cerebral ischemia-reperfusion","volume":"43","author":"Huang","year":"2015","journal-title":"The American Journal of Chinese Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03190635","article-title":"Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells","volume":"31","author":"Huang","year":"2006","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/bs.apha.2019.08.002_bb0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biopha.2018.10.041","article-title":"Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats","volume":"109","author":"Ju","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.apha.2019.08.002_bb0135","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2147\/DDDT.S166525","article-title":"Astragaloside IV\/lncRNA-TUG1\/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats","volume":"12","author":"Lei","year":"2018","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/bs.apha.2019.08.002_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2018.05.037","article-title":"Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378\/TRAF5 signaling pathway","volume":"206","author":"Lei","year":"2018","journal-title":"Life Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2019.08.002_bb0145","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1039\/C5FO01036E","article-title":"Rutin protects against aging-related metabolic dysfunction","volume":"7","author":"Li","year":"2016","journal-title":"Food & Function"},{"key":"10.1016\/bs.apha.2019.08.002_bb0150","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1159\/000486166","article-title":"Astragaloside IV prevents cardiac remodeling in the apolipoprotein E-deficient mice by regulating cardiac homeostasis and oxidative stress","volume":"44","author":"Li","year":"2017","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/bs.apha.2019.08.002_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/fcp.12232","article-title":"Research review on the pharmacological effects of astragaloside IV","volume":"31","author":"Li","year":"2017","journal-title":"Fundamental and Clinical Pharmacology"},{"issue":"2018","key":"10.1016\/bs.apha.2019.08.002_bb0165","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biopha.2017.12.108","article-title":"Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB","volume":"99","author":"Li","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.apha.2019.08.002_bb0170","first-page":"68","article-title":"Progress on chemical constituents and pharmacological effects of Astragali Radix in recent five years","volume":"16","author":"Liu","year":"2014","journal-title":"Food and Drug"},{"issue":"8","key":"10.1016\/bs.apha.2019.08.002_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182558","article-title":"Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.apha.2019.08.002_bb0180","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.4238\/2015.May.22.12","article-title":"Effects of Astragaloside IV on diabetic nephropathy in rats","volume":"14","author":"Lu","year":"2015","journal-title":"Genetics and Molecular Research"},{"issue":"2","key":"10.1016\/bs.apha.2019.08.002_bb0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ptr.2915","article-title":"Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin","volume":"24","author":"Lv","year":"2010","journal-title":"Phytotherapy Research"},{"key":"10.1016\/bs.apha.2019.08.002_bb0190","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3892\/ijmm.2015.2188","article-title":"AST IV inhibits H2O2-induced human umbilical vein endothelial cell apoptosis by suppressing Nox4 expression through the TGF-\u03b21\/Smad2 pathway","volume":"35","author":"Mai","year":"2015","journal-title":"International Journal of Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12192-013-0438-7","article-title":"Astragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells","volume":"19","author":"Qi","year":"2014","journal-title":"Cell Stress & Chaperones"},{"key":"10.1016\/bs.apha.2019.08.002_bb0200","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.2147\/DDDT.S152489","article-title":"Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury","volume":"11","author":"Qiao","year":"2017","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/bs.apha.2019.08.002_bb0205","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3892\/or.2017.5389","article-title":"Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"37","author":"Qin","year":"2017","journal-title":"Oncology Reports"},{"issue":"2","key":"10.1016\/bs.apha.2019.08.002_bb0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13318-018-0515-5","article-title":"Pharmacokinetics comparison, intestinal absorption and acute toxicity assessment of a novel water-soluble astragaloside IV derivative (astragalosidic acid, LS-102)","volume":"44","author":"Qing","year":"2019","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/bs.apha.2019.08.002_bb0215","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/molecules21121616","article-title":"Evaluation and comparison of the inhibition effect of astragaloside IV and aglycone cycloastragenol on various UDP-glucuronosyl transferase (UGT) isoforms","volume":"21","author":"Ran","year":"2016","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/bs.apha.2019.08.002_bb0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0254-6272(13)60189-2","article-title":"Pharmacological effects of Astragaloside IV: A literature review","volume":"33","author":"Ren","year":"2013","journal-title":"Journal of Traditional Chinese Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijdevneu.2012.10.006","article-title":"GAP-43 dependency defines distinct effects of netrin-1 on cortical and spinal neurite outgrowth and directional guidance","volume":"31","author":"Shen","year":"2013","journal-title":"International Journal of Developmental Neuroscience"},{"issue":"5","key":"10.1016\/bs.apha.2019.08.002_bb0230","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/FBP.0000000000000144","article-title":"Antinociceptive activity of astragaloside IV in the animal model of chronic constriction injury","volume":"26","author":"Shi","year":"2015","journal-title":"Behavioural Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2019.08.002_bb0235","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1177\/0300060518778711","article-title":"Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1\/2-ERK1\/2-RSK2 signaling in streptozotocin-induced diabetic mice","volume":"46","author":"Song","year":"2018","journal-title":"Journal of International Medical Research"},{"key":"10.1016\/bs.apha.2019.08.002_bb0240","series-title":"Pharmacopoeia of the People's Republic of China","first-page":"301","author":"State Pharmacopoeia Commission","year":"2015"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3892\/ijmm.2014.1741","article-title":"Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase\/ROS\/Akt\/N-\u03baB pathway under high glucose conditions","volume":"34","author":"Sun","year":"2014","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.apha.2019.08.002_bb0250","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.12659\/MSM.908480","article-title":"Effect of combined use of astragaloside IV (AsIV) and atorvastatin (AV) on expression of PPAR-g and inflammation-associated cytokines in atherosclerosis rats","volume":"24","author":"Sun","year":"2018","journal-title":"Medical Science Monitor"},{"key":"10.1016\/bs.apha.2019.08.002_bb0255","series-title":"Shen Nong Ben Cao Jing","first-page":"112","author":"Sun","year":"2010"},{"key":"10.1016\/bs.apha.2019.08.002_bb0260","doi-asserted-by":"crossref","first-page":"32545","DOI":"10.1038\/srep32545","article-title":"Astragaloside IV ameliorates renal injury in db\/db mice","volume":"6","author":"Sun","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apha.2019.08.002_bb0265","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.phymed.2018.09.019","article-title":"Determination of a astragaloside IV derivative LS-102 in plasma by ultra-performance liquid chromatography-tandem mass spectrometry in dog plasma and its application in a pharmacokinetic study","volume":"53","author":"Sun","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/bs.apha.2019.08.002_bb0270","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1091581810376840","article-title":"Effect of astragaloside IV on the general and peripartum reproductive toxicity in Sprague-Dawley rats","volume":"29","author":"Wan","year":"2010","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/bs.apha.2019.08.002_bb0275","first-page":"345","article-title":"Astragaloside IV inhibits triglyceride accumulation in insulin-resistant HepG2 cells via AMPK-induced SREBP-1c phosphorylation","volume":"9","author":"Wang","year":"2018","journal-title":"Frontiers in Physiology"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0280","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1248\/bpb.32.132","article-title":"Anti-hepatitis B virus activities of astragaloside IV isolated from radix astragali","volume":"32","author":"Wang","year":"2009","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/bs.apha.2019.08.002_bb0285","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3892\/mmr.2017.6924","article-title":"Astragaloside IV downregulates the expression of MDR1 in Bel-7402\/FU human hepatic cancer cells by inhibiting the JNK\/c-Jun\/AP-1 signaling pathway","volume":"16","author":"Wang","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/bs.apha.2019.08.002_bb0290","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.biopha.2018.03.127","article-title":"Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3","volume":"102","author":"Wang","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"11","key":"10.1016\/bs.apha.2019.08.002_bb0295","first-page":"4902","article-title":"Effect of astragaloside IV on diabetic gastric mucosa in vivo and in vitro","volume":"9","author":"Wang","year":"2017","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/bs.apha.2019.08.002_bb0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12882-015-0031-7","article-title":"Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress","volume":"16","author":"Wang","year":"2015","journal-title":"BMC Nephrology"},{"key":"10.1016\/bs.apha.2019.08.002_bb0305","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1021\/mp400031y","article-title":"Synergistic promotion of blood vessel regeneration by astragaloside IV and ferulic acid from electrospun fibrous mats","volume":"10","author":"Wang","year":"2013","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2019.08.002_bb0310","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fphar.2018.00496","article-title":"Astragaloside IV attenuated 3,4-benzopyrene-induced abdominal aortic aneurysm by ameliorating macrophage-mediated inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2019.08.002_bb0315","first-page":"393","article-title":"Astragaloside IV combating liver cirrhosis through the PI3K\/Akt\/mTOR signaling pathway","volume":"17","author":"Wei","year":"2019","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/bs.apha.2019.08.002_bb0320","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3727\/096504016X14685034103590","article-title":"Astragaloside IV enhances cisplatin chemosensitivity in human colorectal cancer via regulating NOTCH3","volume":"24","author":"Xie","year":"2016","journal-title":"Oncology Research"},{"issue":"6","key":"10.1016\/bs.apha.2019.08.002_bb0325","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.3892\/mmr.2016.5167","article-title":"Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6","volume":"13","author":"Yao","year":"2016","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/bs.apha.2019.08.002_bb0330","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1159\/000482025","article-title":"Astragaloside IV induced miR-134 expression reduces EMT and increases chemotherapeutic sensitivity by suppressing CREB1 signaling in colorectal cancer cell line SW-480","volume":"43","author":"Ye","year":"2017","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"4","key":"10.1016\/bs.apha.2019.08.002_bb0335","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5582\/bst.2014.01081","article-title":"Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats","volume":"8","author":"Yin","year":"2014","journal-title":"Bioscience Trends"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0340","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5009\/gnl14118","article-title":"Diagnosis and management of high risk group for gastric cancer","volume":"9","author":"Yoon","year":"2015","journal-title":"Gut and Liver"},{"issue":"3","key":"10.1016\/bs.apha.2019.08.002_bb0345","first-page":"1603","article-title":"Astragaloside IV prevents high glucos-induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells","volume":"19","author":"You","year":"2019","journal-title":"Molecular Medicine Reports"},{"issue":"10","key":"10.1016\/bs.apha.2019.08.002_bb0350","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1055\/s-2008-1081290","article-title":"Astragaloside IV inhibits proliferation and promotes apoptosis in rat vascular smooth muscle cells under high glucose concentration in vitro","volume":"74","author":"Yuan","year":"2008","journal-title":"Planta Medica"},{"issue":"5","key":"10.1016\/bs.apha.2019.08.002_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126603","article-title":"Astragaloside IV attenuates glutamate-induced neurotoxicity in PC12 cells through Raf-MEK-ERK pathway","volume":"10","author":"Yue","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2019.08.002_bb0360","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/ptr.6070","article-title":"Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: Regulation on glycolysis through miRNA-34a\/LDHA pathway","volume":"32","author":"Zhang","year":"2018","journal-title":"Phytotherapy Research"},{"issue":"24","key":"10.1016\/bs.apha.2019.08.002_bb0365","first-page":"2256","article-title":"The mechanism of astragaloside IV promoting sciatic nerve regeneration","volume":"8","author":"Zhang","year":"2013","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/bs.apha.2019.08.002_bb0370","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1039\/C8MD00341F","article-title":"Protective effects of astragaloside IV against hypoxic pulmonary hypertension","volume":"9","author":"Zhang","year":"2018","journal-title":"Medicinal Chemistry Communications"},{"key":"10.1016\/bs.apha.2019.08.002_bb0375","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11010-011-1219-1","article-title":"Astragaloside IV prevents MPP+-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production","volume":"364","author":"Zhang","year":"2012","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/bs.apha.2019.08.002_bb0380","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.lfs.2006.02.032","article-title":"Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs","volume":"79","author":"Zhang","year":"2006","journal-title":"Life Sciences"},{"issue":"11","key":"10.1016\/bs.apha.2019.08.002_bb0385","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00432-014-1744-x","article-title":"Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO","volume":"140","author":"Zhang","year":"2014","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"2","key":"10.1016\/bs.apha.2019.08.002_bb0390","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF03190995","article-title":"Pharmacokinetics of stragaloside iv in beagle dogs","volume":"32","author":"Zhang","year":"2007","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/bs.apha.2019.08.002_bb0395","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3389\/fphys.2018.00795","article-title":"A preclinical systematic review and meta-analysis of astragaloside IV for myocardial ischemia\/reperfusion injury","volume":"9","author":"Zheng","year":"2018","journal-title":"Frontiers in Physiology"},{"issue":"5","key":"10.1016\/bs.apha.2019.08.002_bb0400","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10753-018-0811-x","article-title":"Astragaloside IV inhibits cigarette smoke-induced pulmonary inflammation in mice","volume":"41","author":"Zhou","year":"2018","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/bs.apha.2019.08.002_bb0405","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1745-7254.2008.00712.x","article-title":"Astragaloside IV inhibits spontaneous synaptic transmission and synchronized Ca2+ oscillations on hippocampal neurons","volume":"29","author":"Zhu","year":"2008","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/bs.apha.2019.08.002_bb0410","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jat.1422","article-title":"Effect of astragaloside IV on the embryo-fetal development of Sprague-Dawley rats and New Zealand White rabbits","volume":"29","author":"Zhu","year":"2009","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/bs.apha.2019.08.002_bb0415","first-page":"1","article-title":"Astragaloside IV inhibits TGF-\u03b21-induced epithelial mesenchymal transition through inhibition of the PI3K\/Akt\/NF-\u03baB pathway in gastric cancer cells","volume":"2018","author":"Zhu","year":"2018","journal-title":"Phytotherapy Research"},{"issue":"6","key":"10.1016\/bs.apha.2019.08.002_bb0420","first-page":"1697","article-title":"Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1\/AKT pathway and suppresses the palmitate-induced activation of the IKK\/I\u03baB\u03b1 pathway","volume":"37","author":"Zhu","year":"2016","journal-title":"Internatonal Journal of Molecular Medicine"},{"key":"10.1016\/bs.apha.2019.08.002_bb0425","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.transproceed.2011.02.066","article-title":"Astragaloside IV protects against ischemia reperfusion in a murine model of orthotopic liver transplantation","volume":"43","author":"Cheng","year":"2011","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/bs.apha.2019.08.002_bb0160","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/molecules23082032","article-title":"Astragaloside IV attenuates acetaminophen-induced liver injuries in mice by activating the Nrf2 signaling pathway","volume":"23","author":"Li","year":"2018","journal-title":"Molecules"}],"container-title":["Advances in Pharmacology","Pharmacological Advances in Natural Product Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105435891930064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105435891930064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:46:04Z","timestamp":1760960764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105435891930064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128201855"],"references-count":85,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2019.08.002","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}